# A Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops

> **NCT06209281** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.** · enrollment: 526 (actual)

## Conditions studied

- Myopia

## Interventions

- **DRUG:** Lower dose atropine sulfate eye drops
- **DRUG:** Low dose atropine sulfate eye drops
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT06209281
- **Lead sponsor:** Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-05-13
- **Primary completion:** 2023-08-20
- **Final completion:** 2025-12
- **Target enrollment:** 526 (ACTUAL)
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06209281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06209281, "A Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06209281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*